Jurgi Camblong (SOPH) reports multiple 10b5-1 sales across late 2025–2026
Rhea-AI Filing Summary
SOPH reports multiple Rule 10b5-1 sales by Jurgi Camblong. The filing lists numerous planned sales of Common stock executed under a 10b5-1 plan between
Positive
- None.
Negative
- None.
Insights
Notice lists routine 10b5-1 sales by a reporting person.
The filing catalogs multiple scheduled sales by Jurgi Camblong executed under a 10b5-1 plan across late 2025 and early 2026. The entries show share counts and corresponding proceeds figures for each trade date, indicating systematic dispositions.
Cash‑flow treatment and any remaining holdings are not stated in the excerpt; subsequent filings may provide post‑transaction positions.
FAQ
What does the SOPH Form 144 disclose about insider sales?
Who executed the sales reported in the SOPH filing?
Which trade dates and sample quantities appear in the SOPH excerpt?
Does the filing state how the proceeds are treated for SOPH?